$XXII
22nd Century Group, Inc.

2021 Q3 Form 10-Q Financial Statement

#000155837021010361 Filed on August 05, 2021

View on sec.gov

Income Statement

Concept 2021 Q3 2021 Q2 2020 Q2
Revenue $7.811M $8.371M $6.435M
YoY Change 6.85% 30.09% 10.66%
Cost Of Revenue $7.362M $7.923M $6.234M
YoY Change 5.96% 27.09% 5.64%
Gross Profit $449.0K $448.0K $201.0K
YoY Change 24.03% 122.89% -332.91%
Gross Profit Margin 5.75% 5.35% 3.12%
Selling, General & Admin $6.821M $6.185M $3.501M
YoY Change 115.24% 76.66% 35.38%
% of Gross Profit 1519.15% 1380.58% 1741.79%
Research & Development $856.0K $903.0K $961.0K
YoY Change -5.93% -6.04% -51.63%
% of Gross Profit 190.65% 201.56% 478.11%
Depreciation & Amortization $173.0K $150.0K $157.0K
YoY Change 8.13% -4.46% 6.8%
% of Gross Profit 38.53% 33.48% 78.11%
Operating Expenses $8.018M $7.088M $4.954M
YoY Change 82.14% 43.08% 0.22%
Operating Profit -$7.569M -$6.640M -$4.753M
YoY Change 87.35% 39.7% -5.49%
Interest Expense $23.00K $14.00K $19.00K
YoY Change 0.0% -26.32% 46.15%
% of Operating Profit
Other Income/Expense, Net -$1.871M $2.466M -$304.0K
YoY Change 933.7% -911.18% -89.91%
Pretax Income -$9.440M -$4.174M -$5.057M
YoY Change 123.64% -17.46% -37.12%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$9.440M -$4.174M -$5.057M
YoY Change 123.64% -17.46% -37.12%
Net Earnings / Revenue -120.86% -49.86% -78.59%
Basic Earnings Per Share -$0.06 -$0.03
Diluted Earnings Per Share -$58.01K -$0.03 -$36.42K
COMMON SHARES
Basic Shares Outstanding 162.7M 154.8M
Diluted Shares Outstanding 162.7M 154.8M

Balance Sheet

Concept 2021 Q3 2021 Q2 2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $55.16M $62.32M $28.95M
YoY Change 105.69% 115.29% -38.37%
Cash & Equivalents $1.629M $2.037M $844.0K
Short-Term Investments $53.53M $60.28M $28.10M
Other Short-Term Assets $3.131M $3.943M $3.580M
YoY Change 30.4% 10.14% 181.09%
Inventory $2.703M $2.313M $2.769M
Prepaid Expenses
Receivables $1.179M $2.137M $999.0K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $62.17M $70.71M $36.30M
YoY Change 87.9% 94.83% -30.32%
LONG-TERM ASSETS
Property, Plant & Equipment $4.754M $4.847M $3.500M
YoY Change 45.78% 38.49% -13.86%
Goodwill
YoY Change
Intangibles $8.036M $8.119M $8.239M
YoY Change -2.37% -1.46%
Long-Term Investments $7.300M $9.200M $7.372M
YoY Change 4.06% 24.8% 58.81%
Other Assets $3.713M $3.684M
YoY Change
Total Long-Term Assets $24.28M $26.45M $24.84M
YoY Change -0.12% 6.45% 34.58%
TOTAL ASSETS
Total Short-Term Assets $62.17M $70.71M $36.30M
Total Long-Term Assets $24.28M $26.45M $24.84M
Total Assets $86.46M $97.16M $61.14M
YoY Change 50.62% 58.92% -13.34%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.443M $981.0K $1.019M
YoY Change 29.53% -3.73% -54.12%
Accrued Expenses $3.440M $5.072M $2.235M
YoY Change 9.38% 126.94% -47.68%
Deferred Revenue $0.00 $145.0K $0.00
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $1.782M $2.659M $2.247M
YoY Change 17.01% 18.34% 275.48%
Total Short-Term Liabilities $6.962M $9.243M $6.321M
YoY Change 6.39% 46.23% -11.98%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $292.0K
YoY Change -100.0% -100.0% -47.81%
Other Long-Term Liabilities $479.0K $553.0K $660.0K
YoY Change -9.11% -16.21% 33.74%
Total Long-Term Liabilities $479.0K $553.0K $952.0K
YoY Change -41.51% -41.91% -9.59%
TOTAL LIABILITIES
Total Short-Term Liabilities $6.962M $9.243M $6.321M
Total Long-Term Liabilities $479.0K $553.0K $952.0K
Total Liabilities $7.441M $9.796M $7.273M
YoY Change 1.06% 34.69% -11.67%
SHAREHOLDERS EQUITY
Retained Earnings -$164.0M -$154.6M -$134.8M
YoY Change 18.02% 14.71%
Common Stock $2.000K $2.000K $1.000K
YoY Change 100.0% 100.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $79.01M $87.36M $53.87M
YoY Change
Total Liabilities & Shareholders Equity $86.46M $97.16M $61.14M
YoY Change 50.62% 58.92% -13.34%

Cashflow Statement

Concept 2021 Q3 2021 Q2 2020 Q2
OPERATING ACTIVITIES
Net Income -$9.440M -$4.174M -$5.057M
YoY Change 123.64% -17.46% -37.12%
Depreciation, Depletion And Amortization $173.0K $150.0K $157.0K
YoY Change 8.13% -4.46% 6.8%
Cash From Operating Activities -$5.937M -$8.359M -$6.811M
YoY Change 415.81% 22.73% 67.63%
INVESTING ACTIVITIES
Capital Expenditures -$142.0K -$447.0K -$129.0K
YoY Change 5.19% 246.51% -45.48%
Acquisitions
YoY Change
Other Investing Activities $6.602M -$30.69M $5.412M
YoY Change 143.53% -666.98% 8.56%
Cash From Investing Activities $6.460M -$31.13M $5.283M
YoY Change 150.78% -689.29% 11.26%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -931.0K 40.26M 1.653M
YoY Change 28.06% 2335.33% -513.25%
NET CHANGE
Cash From Operating Activities -5.937M -8.359M -6.811M
Cash From Investing Activities 6.460M -31.13M 5.283M
Cash From Financing Activities -931.0K 40.26M 1.653M
Net Change In Cash -408.0K 765.0K 125.0K
YoY Change -158.45% 512.0% -56.21%
FREE CASH FLOW
Cash From Operating Activities -$5.937M -$8.359M -$6.811M
Capital Expenditures -$142.0K -$447.0K -$129.0K
Free Cash Flow -$5.795M -$7.912M -$6.682M
YoY Change 470.37% 18.41% 74.63%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Entity Central Index Key
EntityCentralIndexKey
0001347858
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
dei Security Exchange Name
SecurityExchangeName
NYSEAMER
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
162685483
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
139061690
CY2021Q2 us-gaap Lessor Operating Lease Term Of Contract
LessorOperatingLeaseTermOfContract
P36M
CY2021Q2 us-gaap Lessor Operating Lease Renewal Term
LessorOperatingLeaseRenewalTerm
P24M
CY2019 xxii Postemployment Benefit Period
PostemploymentBenefitPeriod
P42M
CY2021Q2 xxii Directors And Officers Insurance Policy Term
DirectorsAndOfficersInsurancePolicyTerm
P1Y
CY2021Q2 us-gaap Debt Instrument Term
DebtInstrumentTerm
P9M
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2021-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-36338
dei Entity Registrant Name
EntityRegistrantName
22nd Century Group, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-0468420
dei Entity Address Address Line1
EntityAddressAddressLine1
500 Seneca Street
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 507
dei Entity Address City Or Town
EntityAddressCityOrTown
Buffalo
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
14204
dei City Area Code
CityAreaCode
716
dei Local Phone Number
LocalPhoneNumber
270-1523
dei Security12b Title
Security12bTitle
Common Stock, $0.00001 par value
dei Trading Symbol
TradingSymbol
XXII
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2021Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
162735483
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2037000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1029000
CY2021Q2 us-gaap Short Term Investments
ShortTermInvestments
60284000
CY2020Q4 us-gaap Short Term Investments
ShortTermInvestments
21313000
CY2021Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2137000
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2159000
CY2021Q2 us-gaap Inventory Net
InventoryNet
2313000
CY2020Q4 us-gaap Inventory Net
InventoryNet
2034000
CY2021Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3943000
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1806000
CY2021Q2 us-gaap Assets Current
AssetsCurrent
70714000
CY2020Q4 us-gaap Assets Current
AssetsCurrent
28341000
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4847000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2483000
CY2021Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
595000
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
247000
CY2021Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
8119000
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
8211000
CY2021Q2 us-gaap Long Term Investments
LongTermInvestments
9200000
CY2020Q4 us-gaap Long Term Investments
LongTermInvestments
6536000
CY2021Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3684000
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
5876000
CY2021Q2 us-gaap Assets
Assets
97159000
CY2020Q4 us-gaap Assets
Assets
51694000
CY2021Q2 us-gaap Notes Payable Current
NotesPayableCurrent
2659000
CY2020Q4 us-gaap Notes Payable Current
NotesPayableCurrent
539000
CY2021Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
174000
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
247000
CY2021Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
981000
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1116000
CY2021Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5072000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4830000
CY2021Q2 us-gaap Postemployment Benefits Liability Current
PostemploymentBenefitsLiabilityCurrent
212000
CY2020Q4 us-gaap Postemployment Benefits Liability Current
PostemploymentBenefitsLiabilityCurrent
339000
CY2021Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
145000
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
272000
CY2021Q2 us-gaap Liabilities Current
LiabilitiesCurrent
9243000
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
7343000
CY2021Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
423000
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
0
CY2021Q2 us-gaap Postemployment Benefits Liability Noncurrent
PostemploymentBenefitsLiabilityNoncurrent
130000
CY2020Q2 us-gaap Operating Expenses
OperatingExpenses
4954000
us-gaap Operating Expenses
OperatingExpenses
13044000
us-gaap Operating Expenses
OperatingExpenses
9384000
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-6640000
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-4753000
us-gaap Operating Income Loss
OperatingIncomeLoss
-11811000
us-gaap Adjustment For Amortization
AdjustmentForAmortization
303000
us-gaap Adjustment For Amortization
AdjustmentForAmortization
361000
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
7226000
CY2020Q4 us-gaap Postemployment Benefits Liability Noncurrent
PostemploymentBenefitsLiabilityNoncurrent
241000
CY2021Q2 us-gaap Liabilities
Liabilities
9796000
CY2020Q4 us-gaap Liabilities
Liabilities
7584000
CY2021Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2021Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
162685483
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
139061690
CY2021Q2 us-gaap Common Stock Value
CommonStockValue
2000
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
1000
CY2021Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
241968000
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
189439000
CY2021Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1000
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
74000
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-154608000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-145404000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
87363000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
44110000
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
97159000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
51694000
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
8371000
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6435000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
15177000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
13493000
CY2021Q2 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
7785000
CY2020Q2 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
6234000
us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
13944000
us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
13005000
CY2021Q2 xxii Gross Profit Excluding Depreciation
GrossProfitExcludingDepreciation
586000
CY2020Q2 xxii Gross Profit Excluding Depreciation
GrossProfitExcludingDepreciation
201000
xxii Gross Profit Excluding Depreciation
GrossProfitExcludingDepreciation
1233000
xxii Gross Profit Excluding Depreciation
GrossProfitExcludingDepreciation
488000
CY2021Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6177000
CY2020Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3501000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
11006000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6640000
CY2020Q2 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
146000
us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
146000
CY2021Q2 us-gaap Depreciation
Depreciation
150000
CY2020Q2 us-gaap Depreciation
Depreciation
157000
us-gaap Depreciation
Depreciation
288000
us-gaap Depreciation
Depreciation
313000
CY2021Q2 us-gaap Adjustment For Amortization
AdjustmentForAmortization
153000
CY2020Q2 us-gaap Adjustment For Amortization
AdjustmentForAmortization
189000
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-133000
us-gaap Operating Income Loss
OperatingIncomeLoss
-8896000
CY2021Q2 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-176000
CY2020Q2 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
312000
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-140000
CY2020Q2 us-gaap Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
1062000
us-gaap Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
1062000
CY2021Q2 xxii Debt Securities Realized Gain Loss On Conversion
DebtSecuritiesRealizedGainLossOnConversion
2548000
xxii Debt Securities Realized Gain Loss On Conversion
DebtSecuritiesRealizedGainLossOnConversion
2548000
CY2020Q2 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
3000
CY2021Q2 us-gaap Investment Income Net
InvestmentIncomeNet
108000
CY2020Q2 us-gaap Investment Income Net
InvestmentIncomeNet
462000
us-gaap Investment Income Net
InvestmentIncomeNet
220000
us-gaap Investment Income Net
InvestmentIncomeNet
1074000
CY2021Q2 us-gaap Interest Expense
InterestExpense
14000
CY2020Q2 us-gaap Interest Expense
InterestExpense
19000
us-gaap Interest Expense
InterestExpense
21000
us-gaap Interest Expense
InterestExpense
31000
CY2021Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2466000
CY2020Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-304000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2607000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-152000
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4174000
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5057000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-9204000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-9048000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
38000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-4174000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-5057000
us-gaap Net Income Loss
NetIncomeLoss
-9204000
us-gaap Net Income Loss
NetIncomeLoss
-9086000
CY2021Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-41000
CY2020Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
241000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-73000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
45000
CY2020Q2 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
3000
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-41000
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
238000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-73000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
45000
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4215000
CY2020Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4819000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-9277000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-9041000
CY2021Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.03
CY2020Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.04
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.06
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.07
CY2021Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
154811000
CY2020Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
138854000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
149564000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
138732000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
44110000
CY2021Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
0
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1153000
CY2021Q1 xxii Stock Issued During Period Value Warrants Exercise
StockIssuedDuringPeriodValueWarrantsExercise
11782000
CY2021Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
507000
CY2021Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax
-32000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-5030000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
52490000
CY2021Q2 xxii Stock Issued During Period Value Restricted Stock Award Net Of Shares Withheld For Taxes
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfSharesWithheldForTaxes
-469000
CY2021Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
106000
CY2021Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
38206000
CY2021Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1245000
CY2021Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax
-41000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-4174000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
87363000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
62050000
CY2020Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
480000
CY2020Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax
-196000
CY2020Q1 us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
3000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-4029000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
58308000
CY2020Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
376000
CY2020Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax
241000
CY2020Q2 us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
-3000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-5057000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
53865000
us-gaap Profit Loss
ProfitLoss
-9204000
us-gaap Profit Loss
ProfitLoss
-9086000
us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
146000
us-gaap Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
1062000
xxii Amortization And Depreciation Excluding Amortization Of Intangibles
AmortizationAndDepreciationExcludingAmortizationOfIntangibles
466000
xxii Amortization And Depreciation Excluding Amortization Of Intangibles
AmortizationAndDepreciationExcludingAmortizationOfIntangibles
549000
xxii Amortization Of License Fees
AmortizationOfLicenseFees
124000
xxii Amortization Of License Fees
AmortizationOfLicenseFees
125000
us-gaap Operating Lease Cost
OperatingLeaseCost
149000
us-gaap Operating Lease Cost
OperatingLeaseCost
151000
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-140000
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-133000
xxii Debt Securities Realized Gain Loss On Conversion
DebtSecuritiesRealizedGainLossOnConversion
2548000
us-gaap Accretion Expense
AccretionExpense
4000
us-gaap Accretion Expense
AccretionExpense
12000
xxii Accretion Income
AccretionIncome
85000
xxii Accretion Income
AccretionIncome
306000
us-gaap Share Based Compensation
ShareBasedCompensation
1752000
us-gaap Share Based Compensation
ShareBasedCompensation
856000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-21000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
132000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
280000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
503000
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
2307000
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
2934000
xxii Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-148000
xxii Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-149000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-140000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1032000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
151000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-384000
us-gaap Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
-238000
us-gaap Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
24000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-127000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-5000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-12270000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-11473000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
179000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
198000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
388000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
42000
us-gaap Proceeds From Sale And Maturity Of Trading Securities Heldforinvestment
ProceedsFromSaleAndMaturityOfTradingSecuritiesHeldforinvestment
19037000
us-gaap Proceeds From Sale And Maturity Of Trading Securities Heldforinvestment
ProceedsFromSaleAndMaturityOfTradingSecuritiesHeldforinvestment
19272000
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
58137000
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
8853000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-39667000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
10179000
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
538000
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
542000
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
2653000
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
2195000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1259000
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
11782000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
38258000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
469000
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
1183000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
1183000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
52945000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1653000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1008000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
359000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1029000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
485000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2037000
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
844000
us-gaap Interest Paid Net
InterestPaidNet
8000
us-gaap Interest Paid Net
InterestPaidNet
6000
xxii Patent And Trademark Additions Included In Accounts Payable
PatentAndTrademarkAdditionsIncludedInAccountsPayable
54000
xxii Property Plant And Equipment Additions Included In Accounts Payable
PropertyPlantAndEquipmentAdditionsIncludedInAccountsPayable
9000
xxii Property Plant And Equipment Additions Included In Accounts Payable
PropertyPlantAndEquipmentAdditionsIncludedInAccountsPayable
0
xxii Property Plant And Equipment Additions Included In Accrued Expenses
PropertyPlantAndEquipmentAdditionsIncludedInAccruedExpenses
7000
xxii Right Of Use Assets And Corresponding Operating Lease Obligations
RightOfUseAssetsAndCorrespondingOperatingLeaseObligations
497000
xxii Right Of Use Assets And Corresponding Operating Lease Obligations
RightOfUseAssetsAndCorrespondingOperatingLeaseObligations
198000
xxii Patent And Trademark Additions Included In Accrued Liabilities Current
PatentAndTrademarkAdditionsIncludedInAccruedLiabilitiesCurrent
32000
xxii Noncash Stock Issuance Fees
NoncashStockIssuanceFees
52000
xxii Noncash Investment Conversion
NoncashInvestmentConversion
12485000
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Use of Estimates</span><i style="font-style:italic;"> </i><b style="font-weight:bold;">-</b><i style="font-style:italic;"> </i>The preparation of financial statements in conformity with accounting principles generally accepted in the U.S. requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period. Actual results could differ from those estimates.</p>
xxii Number Of Subsidiaries
NumberOfSubsidiaries
4
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Reclassifications </span><i style="font-style:italic;">–</i><span style="font-style:italic;font-weight:bold;"> </span> Certain prior period amounts have been reclassified to conform to the current period’s classification. None of these reclassifications had a material impact on our consolidated financial statements.</p>
CY2021Q2 xxii Inventory Tobacco Leaf Gross
InventoryTobaccoLeafGross
863000
CY2020Q4 xxii Inventory Tobacco Leaf Gross
InventoryTobaccoLeafGross
821000
CY2021Q2 xxii Inventory Hemp Cannabis Gross
InventoryHempCannabisGross
68000
CY2021Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
193000
CY2020Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
171000
CY2021Q2 xxii Inventory Raw Materials Excluding Tobacco Leaf
InventoryRawMaterialsExcludingTobaccoLeaf
1289000
CY2020Q4 xxii Inventory Raw Materials Excluding Tobacco Leaf
InventoryRawMaterialsExcludingTobaccoLeaf
1142000
CY2021Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
100000
CY2020Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
100000
CY2021Q2 us-gaap Inventory Net
InventoryNet
2313000
CY2020Q4 us-gaap Inventory Net
InventoryNet
2034000
CY2021Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2956000
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2670000
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4847000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2483000
CY2021Q2 us-gaap Depreciation
Depreciation
150000
us-gaap Depreciation
Depreciation
288000
CY2020Q2 us-gaap Depreciation
Depreciation
157000
us-gaap Depreciation
Depreciation
313000
CY2021Q2 xxii Lessee Operating Lease Number Of Renewal Options
LesseeOperatingLeaseNumberOfRenewalOptions
2
CY2021Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y6M
CY2021Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.038
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
146000
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
85000
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
78000
CY2021Q2 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
9997000
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
80000
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
82000
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
192000
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
663000
CY2021Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
66000
CY2021Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
597000
CY2021Q2 us-gaap Long Term Investments
LongTermInvestments
9200000
CY2020Q4 us-gaap Long Term Investments
LongTermInvestments
6536000
CY2020Q4 us-gaap Notes Receivable Related Parties Noncurrent
NotesReceivableRelatedPartiesNoncurrent
5876000
CY2021Q2 us-gaap Notes Receivable Related Parties Noncurrent
NotesReceivableRelatedPartiesNoncurrent
3684000
CY2020Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
11288000
us-gaap Fair Value Assets Measured On Recurring Basis Change In Unrealized Gain Loss
FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
-140000
xxii Accreted Interest Income On Convertible Note Receivable
AccretedInterestIncomeOnConvertibleNoteReceivable
142000
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements
11192000
CY2021Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
98000
CY2020Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
23652000
CY2020Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
74000
CY2020Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
0
CY2020Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
23726000
CY2021Q2 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
6394000
CY2021Q2 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
6409000
CY2020Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
11692000
CY2020Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
11753000
CY2021Q2 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
9983000
CY2020Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
11960000
CY2020Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
11973000
CY2021Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
16391000
CY2021Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
16392000
CY2020Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
23652000
CY2020Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
23726000
CY2021Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
8119000
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
8211000
CY2021Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
153000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
303000
CY2020Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
189000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
361000
us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
146000
CY2020Q2 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
146000
xxii Finite Lived Intangible Assets Written Off Due To Impairment Cost
FiniteLivedIntangibleAssetsWrittenOffDueToImpairmentCost
448000
CY2020Q2 xxii Finite Lived Intangible Assets Written Off Due To Impairment Cost
FiniteLivedIntangibleAssetsWrittenOffDueToImpairmentCost
448000
xxii Finite Lived Intangible Assets Written Off Due To Impairment Accumulated Amortization
FiniteLivedIntangibleAssetsWrittenOffDueToImpairmentAccumulatedAmortization
302000
CY2020Q2 xxii Finite Lived Intangible Assets Written Off Due To Impairment Accumulated Amortization
FiniteLivedIntangibleAssetsWrittenOffDueToImpairmentAccumulatedAmortization
302000
CY2021Q2 xxii Directors And Officers Insurance Premium
DirectorsAndOfficersInsurancePremium
3315000
CY2021Q2 xxii Directors And Officers Insurance Premium Paid
DirectorsAndOfficersInsurancePremiumPaid
662000
CY2021Q2 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
2653000
CY2021Q2 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.0349
CY2020Q2 xxii Directors And Officers Insurance Policy Term
DirectorsAndOfficersInsurancePolicyTerm
P1Y
CY2020Q2 xxii Directors And Officers Insurance Premium
DirectorsAndOfficersInsurancePremium
2744000
CY2020Q2 xxii Directors And Officers Insurance Premium Paid
DirectorsAndOfficersInsurancePremiumPaid
549000
CY2020Q2 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
2195000
CY2020Q2 us-gaap Debt Instrument Term
DebtInstrumentTerm
P9M
CY2020Q2 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.0319
CY2021Q2 xxii License Fees Payable Current
LicenseFeesPayableCurrent
297000
CY2020Q4 xxii License Fees Payable Current
LicenseFeesPayableCurrent
293000
CY2021Q2 xxii Directors And Officers Insurance Payable Current
DirectorsAndOfficersInsurancePayableCurrent
2362000
CY2020Q4 xxii Directors And Officers Insurance Payable Current
DirectorsAndOfficersInsurancePayableCurrent
246000
CY2021Q2 us-gaap Notes Payable Current
NotesPayableCurrent
2659000
CY2020Q4 us-gaap Notes Payable Current
NotesPayableCurrent
539000
CY2020Q2 us-gaap Postemployment Benefits Period Expense
PostemploymentBenefitsPeriodExpense
306000
CY2019 us-gaap Postemployment Benefits Period Expense
PostemploymentBenefitsPeriodExpense
881000
CY2019Q4 us-gaap Supplemental Unemployment Benefits Severance Benefits
SupplementalUnemploymentBenefitsSeveranceBenefits
771000
CY2021Q2 us-gaap Postemployment Benefits Liability Current
PostemploymentBenefitsLiabilityCurrent
212000
CY2021Q2 us-gaap Postemployment Benefits Liability Noncurrent
PostemploymentBenefitsLiabilityNoncurrent
130000
CY2020Q4 us-gaap Postemployment Benefits Liability Current
PostemploymentBenefitsLiabilityCurrent
339000
CY2020Q4 us-gaap Postemployment Benefits Liability Noncurrent
PostemploymentBenefitsLiabilityNoncurrent
241000
CY2021Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
10000000
CY2021Q2 us-gaap Share Price
SharePrice
4.00
CY2021Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
38206000
CY2021Q1 xxii Number Of Warrants Exercised
NumberOfWarrantsExercised
11293211
CY2021Q1 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
11782000
CY2020Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
11293211
CY2021Q1 xxii Number Of Warrants Exercised
NumberOfWarrantsExercised
11293211
CY2021Q2 us-gaap Contractual Obligation Future Minimum Payments Due Remainder Of Fiscal Year
ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear
843000
CY2021Q2 us-gaap Contractual Obligation Due In Next Twelve Months
ContractualObligationDueInNextTwelveMonths
1535000
CY2021Q2 us-gaap Contractual Obligation Due In Second Year
ContractualObligationDueInSecondYear
1310000
CY2021Q2 us-gaap Contractual Obligation Due In Third Year
ContractualObligationDueInThirdYear
1337000
CY2021Q2 xxii Contractual Obligation Due After Fourth Year
ContractualObligationDueAfterFourthYear
4103000
CY2021Q2 us-gaap Contractual Obligation
ContractualObligation
9128000
CY2019Q4 us-gaap Loss Contingency Pending Claims Number
LossContingencyPendingClaimsNumber
3
CY2020Q1 us-gaap Loss Contingency Pending Claims Number
LossContingencyPendingClaimsNumber
3
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
5000000
xxii Share Based Compensation Arrangement Plan Term
ShareBasedCompensationArrangementPlanTerm
P10Y
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
7089486
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
2938000
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
0.85
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
1995000
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.20
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
1234000
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
0.85
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
216000
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
0.67
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
3483000
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
2.21
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
15000
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
4.60
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
288000
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
0.86
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
25000
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
1.04
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
3185000
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
2.35
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
4903000
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
6581000
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.50
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
235000
CY2021Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
3.10
CY2021Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
846000
CY2021Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.36
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
6000
CY2021Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
2.76
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5964000
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.59
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y3M18D
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
7480000
CY2021Q2 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
88000
CY2021Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.21
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
100000
CY2021Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0.80
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5776000
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.60
CY2021Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y1M6D
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
13265000
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
4940000
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
1.57
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P3Y10M24D
CY2021Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
14068000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0054
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.8792
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y1M2D
CY2021Q2 us-gaap Share Based Compensation
ShareBasedCompensation
1245000
CY2020Q2 us-gaap Share Based Compensation
ShareBasedCompensation
376000
us-gaap Share Based Compensation
ShareBasedCompensation
1752000
us-gaap Share Based Compensation
ShareBasedCompensation
856000
CY2021Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
6676000
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y3M18D
CY2021Q2 xxii Employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptionswithmilestonebasedvesting
Employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptionswithmilestonebasedvesting
581000
CY2021Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0
xxii Contract Asset Payment Period After Shipment
ContractAssetPaymentPeriodAfterShipment
P21D
CY2021Q2 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
300000
CY2020Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
349000
CY2021Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
145000
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
272000
CY2021Q2 xxii Contract Asset Liability Net
ContractAssetLiabilityNet
155000
CY2020Q4 xxii Contract Asset Liability Net
ContractAssetLiabilityNet
77000
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
8371000
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6435000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
15177000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
13493000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-4174000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-5057000
us-gaap Net Income Loss
NetIncomeLoss
-9204000
us-gaap Net Income Loss
NetIncomeLoss
-9086000
CY2021Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
154811000
CY2020Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
138854000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
149564000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
138732000
CY2021Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.03
CY2020Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.04
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.06
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.07
CY2021Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8961000
CY2020Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
21660000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8961000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
21660000

Files In Submission

Name View Source Status
0001558370-21-010361-index-headers.html Edgar Link pending
0001558370-21-010361-index.html Edgar Link pending
0001558370-21-010361.txt Edgar Link pending
0001558370-21-010361-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
xxii-20210630.xsd Edgar Link pending
xxii-20210630x10q.htm Edgar Link pending
xxii-20210630x10q_htm.xml Edgar Link completed
xxii-20210630xex10d1.htm Edgar Link pending
xxii-20210630xex10d2.htm Edgar Link pending
xxii-20210630xex10d3.htm Edgar Link pending
xxii-20210630xex31d1.htm Edgar Link pending
xxii-20210630xex31d2.htm Edgar Link pending
xxii-20210630xex32d1.htm Edgar Link pending
xxii-20210630_cal.xml Edgar Link unprocessable
xxii-20210630_def.xml Edgar Link unprocessable
xxii-20210630_lab.xml Edgar Link unprocessable
xxii-20210630_pre.xml Edgar Link unprocessable